Cargando…
Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis
OBJECTIVES: To determine (i) correlates for etanercept (ETA) discontinuation after achieving an inactive disease and for the subsequent risk of flare and (ii) to analyze the effectiveness of ETA in the re-treatment after a disease flare. METHODS: Data from two ongoing prospective registries, BiKeR a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050932/ https://www.ncbi.nlm.nih.gov/pubmed/33863349 http://dx.doi.org/10.1186/s13075-021-02492-0 |